Anesthesia & Analgesia · 2016 · 56 citations · 23 references
MedicineOncologyPharmacologyCancer PharmacologyCell SignalingMolecular OncologyCancer BiomarkersCancer Cell SignalingMalignant NeoplasmsOncology PharmacologyOpioid PharmacologySignal Transduction In CancerCancer Cell Line ModelsEndogenous OpioidsGrowth Factor Receptor OverexpressionOpioid Receptor BindingReceptors
BACKGROUND: There have been inconsistent reports on whether opioids promote or inhibit lung cancer growth. In this study, we suggest that opioid growth factor receptor (OGFR), a negative regulator of cell proliferation, is a binding site of morphine and is involved in subsequent morphine-induced lung cancer growth suppression. METHODS: The expression and distribution of OGFR in human lung cancer tissues and cell lines were assessed with immunohistochemistry and real-time reverse transcription polymerase chain reaction. The human lung cancer cell line, H1975 (adenocarcinoma), which overexpressed OGFR but not μ-opioid receptors, was selected for further analysis to verify the interaction between morphine and OGFR and the impact of morphine on cancer cell growth. RESULTS: OGFR was expressed in lung cancer tissues and all cancer cell lines tested. Adenocarcinoma showed a higher OGFR expression than squamous cell carcinoma (reverse transcription polymerase chain reaction relative quantitation value: median [interquartile range], 13.1 [9.3-20.0] vs 4.3 [2.2-6.6]; P = 0.003). OGFR expression showed an inverse correlation with cell proliferation (r = -0.92, P = 0.0001). Morphine treatment reduced the median H1975 cell number by approximately 23% (P = 0.03). Growth suppression by morphine was attenuated when OGFR was knocked down. A confocal experiment demonstrated binding of morphine to OGFR. Growth suppression by morphine occurred in the S phase of the cell cycle. CONCLUSIONS: Lung cancer tissues and cell lines express OGFR. Morphine interacts with OGFR and may suppress lung cancer progression.
23
Anesthetic Technique for Radical Prostatectomy Surgery Affects Cancer Recurrence
Barbara Biki, Edward J. Mascha, Denis C. Moriarty et al. · Anesthesiology · 2008 · 606 citations · Full text
Medicine, Anesthesiology, Surgery +11
The Novel Role of the Mu Opioid Receptor in Lung Cancer Progression
Biji Mathew, Frances E. Lennon, Jessica Siegler et al. · Anesthesia & Analgesia · 2010 · 260 citations
Medicine, Oncology, Pharmacology +16
Frances E. Lennon, Tamara Mirzapoiazova, Bolot Mambetsariev et al. · PLoS ONE · 2014 · 208 citations · Full text
Medicine, Oncology, Pharmacology +17